Masimo at 15TH CONGRESS OF ALL-RUSSIAN NON-GOVERNMENTAL ORGANIZATION FEDERATION OF ANESTHESIOLOGISTS AND REANIMATOLOGISTSWritten by Super User
We are pleased to announce that this year Masimo will participate again in the well-known Congress for Anesthesiologists and Reanimatologists in Russia, which will take place in Moscow, in the Hotel COSMOS, 17-20th of September.
This year Masimo stands as one of the Sponsors of the Event and will be happy to see its customers at the trade show, Booth B9!
See you soon!
Oxygen Delivery (DO2): An Oversimplified Concept?
15th-16th September 2016 Professor Azriel Perel will give a presentation, followed by an interactive session and discussion. To favor interactivity, we cordially invite surgical, anaesthetic, critical care, emergency medicine, haematology staff and trainees to join us.
15th September – 12.00 – 14.00 – "Research Center for Heart, Blood and Endocrinology named by Almazov”, Russia, St. Petersburg
16th September – 13.00 – 14.00 – "Research Center for Obstetrics, Gynecology and Perinatology named by V.I. Kulakov" Ministry of Health, Russia, Moscow
New Clinical Study Reports Relationship Between Masimo's Oxygen Reserve Index (ORI™) and Arterial Partial Pressure of Oxygen During Surgery
Neuchatel, Switzerland – March 31, 2016 – Masimo (NASDAQ: MASI) announced today that a new retrospective study reports the relationship between Masimo's Oxygen Reserve Index (ORI™) and arterial partial pressure of oxygen (PaO2) during surgery. The study suggests that ORI may provide an advanced indication of impending desaturation in adults undergoing surgery based on trends in the relationship between ORI and PaO2.1
Masimo Root® with ORI™
In the study, published in the journal Anesthesia & Analgesia and conducted at Loma Linda University, Dr. Applegate and colleagues studied 106 patients in which arterial catheterization and intraoperative arterial blood gas analysis were planned during surgery. Multiwavelength Pulse CO-oximetry data from multiple sensors on each patient were continuously collected (Masimo Radical-7® with Root®). A retrospective analysis was then conducted to evaluate the ORI to PaO2relationship.
Regression analysis showed a positive ORI to PaO2 relationship for PaO2 values up to 240 mm Hg (r2 = 0.536), but not for PaO2 over 240 mm Hg (r2 = 0.0016). Measured PaO2 was ≥100 mm Hg for all ORI values over 0.24, and when ORI was higher than 0.55, the measured PaO2 was ≥150 mm Hg in 96.6% of samples.
The investigators concluded, "This study suggests that intraoperative ORI can distinguish PaO2 between 100 and 150 mm Hg when SpO2 is >98%. Decreases in ORI to near 0.24 may provide advance indication of falling PaO2 when SpO2 is still >98% and above the PaO2 level at which SaO2 [arterial oxygen saturation] declines rapidly. Usefulness of ORI >0.24 to distinguish PaO2 ≥100 mm Hg and ORI >0.55 to distinguish PaO2 ≥150 mm Hg should be tested prospectively in a range of clinical settings." Additionally, the investigators noted that "the clinical utility of interventions based on continuous ORI monitoring should also be studied prospectively," and that other clinical or feasibility limitations may not have been identified. The authors also noted that the study was limited by a small number of subjects and samples with PaO2 values <100 mm Hg, and that the study results did not apply to intensive care settings.
The Loma Linda University School of Medicine, Department of Anesthesiology received a grant from Masimo to support the data collection for this study.
Radical-7 with Root has a CE Mark with the ORI parameter. ORI has not received FDA 510(k) clearance and is not available for sale in the United States.